Sartorius Stedim Biotech S.A. (EPA:DIM)

Market Cap	19.71B
Revenue (ttm)	2.95B
Net Income (ttm)	263.90M
Shares Out	97.30M
EPS (ttm)	2.71
PE Ratio	74.77
Forward PE	39.37
Dividend	0.69 (0.34%)
Ex-Dividend Date	Apr 2, 2025

Volume	11,558
Average Volume	81,244
Open	205.00
Previous Close	202.60
Day's Range	203.10 - 205.80
52-Week Range	148.75 - 239.80
Beta	0.89
RSI	66.24
Earnings Date	Oct 16, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 9,901
• Stock Exchange: Euronext Paris
• Ticker Symbol: DIM

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.